Neurocognitive performance following acute mephedrone administration, with and without alcohol
EB de Sousa Fernandes Perna, Esther Papaseit, Clara Pérez‐mañá, Jazmine Mateus, EL Theunissen, Kim P. C. Kuypers, Rafael de la Torre, Magı́ Farré, Jg Ramaekers
Journal of Psychopharmacology August 25, 2016 DOI: 10.1177/0269881116662635 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 11 |
| Population | Healthy human participants |
| Interventions | Mephedrone Alcohol |
| Dose | 200 mg mephedrone; 0.8 g/kg alcohol |
| Duration | Single-dose administration, assessments at baseline, one hour, and four hours post-dose |
| Measures | Divided Attention Task (DAT), Critical Tracking Task (CTT), Spatial Memory Test (SMT) |
| Keywords | Mephedrone Neurocognitive Placebo Psychomotor learning Alcohol Pharmacology Anesthesia Cognition Drug |
| Citations | 26 |
| Key findings | Mephedrone improves psychomotor performance (critical tracking) but impairs short-term spatial memory, and does not counteract alcohol's impairing effects on most cognitive measures. |
Abstract
Recreational use of mephedrone, alone and in combination with alcohol, has increased over the past years. Pharmacological properties of mephedrone share similarities with methylenedioxymethamphetamine (MDMA), but its effect on neurocognitive function has not been well established in humans. The present study assessed the effect of mephedrone alone and after co-administration with alcohol on neurocognitive function. It was hypothesised that mephedrone would improve psychomotor performance but impair memory performance, when administered alone. Neurocognitive performance was expected to be impaired following mephedrone when combined with alcohol. Eleven participants received single doses of 200 mg mephedrone or placebo combined with 0.8 g/kg alcohol or placebo. Neurocognitive performance was assessed at baseline (T 0 ), at one hour (T 1 ) and four hours after (T 2 ) mephedrone administration, by means of the Divided Attention Task (DAT), Critical Tracking Task (CTT), and the Spatial Memory Test (SMT). Mephedrone intoxication impaired short-term spatial memory at T 1 and improved critical tracking performance at T 2 . Mephedrone alone did not affect divided attention, but did show an interaction with alcohol on reaction time at T 2 . Reaction time decreased when mephedrone was combined with alcohol as compared to alcohol alone. Alcohol intoxication impaired both short- and long-term spatial memory at T 1 and divided attention at T 1 and T 2 . Critical tracking performance was not affected by alcohol intoxication. The current findings support the hypothesis that mephedrone improves psychomotor performance, impairs spatial memory and does not affect divided attention performance. Stimulatory effects of mephedrone were not sufficient to compensate for the impairing effects of alcohol on most performance parameters.
Citations in the library
Cited by 11
- New/emerging psychoactive substances and associated psychopathological consequences Psychological Medicine July 22, 2019
- An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users Psychopharmacology June 26, 2018
- Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study British Journal of Pharmacology November 22, 2017
- Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans Pharmaceuticals January 28, 2021
- Mephedrone and Alcohol Interactions in Humans Frontiers in Pharmacology January 28, 2020
and 6 more in the library
Cites 12
- Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users Psychopharmacology October 30, 2010
- Dissociable Effects of a Single Dose of Ecstasy (MDMA) on Psychomotor Skills and Attentional Performance Journal of Psychopharmacology December 1, 2003
- Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine Journal of Psychopharmacology November 1, 2005
- The preclinical pharmacology of mephedrone; not justMDMAby another name British Journal of Pharmacology March 24, 2014
- Blockade of 5-HT2 Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment Neuropsychopharmacology May 11, 2011
and 7 more in the library